This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Trinity Biotech plc develops, manufactures, and markets diagnostic test kits and instruments for clinical laboratories, including tests for infectious diseases, autoimmune disorders, and hemoglobin analysis. The company's product development pipeline includes in vitro diagnostics and biotherapeutics, which involve animal testing as part of the regulatory approval process. For example, its investigational new drug (IND) application for GTB-5550 progressed from lab and animal testing into human clinical trials.
A 2024 regulatory-compliant oral toxicity study published in a peer-reviewed journal lists Trinity Biotech PLC as the supplier of clinical chemistry analysis services for the research. The study, which investigated the effects of a soluble fullerene derivative, was conducted on rats, which the authors note are the preferred model for such toxicological assessments. This indicates the company provides testing services that are integral to animal-based research protocols required for product safety evaluation.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.